Gene Therapy for Cystic Fibrosis: Restoring CFTR Function
Cystic fibrosis (CF) is caused by mutations in the CFTR gene (chromosome 7), leading to defective chloride/bicarbonate transport. Gene therapy aims to deliver a functional CFTR copy to airway epithelial cells.
Approaches
| Vector | Examples | Status |
|---|---|---|
| Viral (AAV, lentivirus) | AAV2/5, AAV1, lentiviral pseudotypes | Preclinical; AAV trials showed transient expression, immune responses |
| Non-viral (liposome, nanoparticle) | GL67A/pGM169 (UK Cystic Fibrosis Gene Therapy Consortium) | Phase 2b (2015): modest FEV₁ stabilization vs. placebo; not commercialized |
| mRNA / lipid nanoparticle | Translate Bio (MRT5005), Moderna | Phase 1/2 ongoing; repeat dosing feasible |
| Gene editing (CRISPR/Cas) | Base editing, prime editing of CFTR mutations | Preclinical; delivery to airway stem cells remains challenge |
Key Challenges
- Airway mucus barrier & rapid epithelial turnover (30–60 days) → need repeat dosing or stem cell targeting.
- Immune response to vector/transgene.
- Large CFTR cDNA (4.4 kb) exceeds AAV packaging limit (~4.7 kb with promoter) — requires dual vectors or truncated versions.
- Need >5–10% corrected cells for clinical benefit.
Current Standard of Care
CFTR modulators (ivacaftor, lumacaftor/ivacaftor, tezacaftor/ivacaftor, elexacaftor/tezacaftor/ivacaftor) treat ~90% of patients by rescuing mutant protein function. Gene therapy remains investigational for non-responders or ineligible genotypes.
Gene therapy for CF is a logical but still experimental strategy; modulator therapy has transformed outcomes for most.
Genetic Disorders - Related Articles
- Meiotic Errors: Nondisjunction, Recombination Defects, and Consequences
- Syndrome (The Incredibles): Character Analysis of a Villain’s Psychology
- Keratin Complex Treatments: Risks, Hazards & Safety Precautions
- Tay-Sachs Disease: Understanding Parental Genotypes and Inheritance
- Understanding and Diagnosing Triple X Syndrome: Symptoms & Testing
- Borderline Personality Disorder (BPD) Screening Tools and Self-Assessment Resources
- External Mutagens: Radiation, Chemicals, UV, Oxidants, Viruses, and Transposons
